Jocasta Neuroscience
PrivateLast Round
Series A
Aug 12, 2025
Total Funding Raised
$35M
Company Overview
Jocasta Neuroscience operates in Healthcare & Life Sciences and is based in Scottsdale, Arizona. Its latest recorded funding round was a Series A round in August 2025.
Jocasta Neuroscience is a biotechnology company that develops proprietary alpha-Klotho protein formulations to treat cognitive decline associated with neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jocasta Neuroscience Comparables
Compare Jocasta Neuroscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Klotho Therapeutics, Inc. | 87% | |
| ADvantage Therapeutics Inc. | 84% | |
| Klogene Therapeutics, Inc. | 81% |
For institutional investors. Book with your work email.
Jocasta Neuroscience Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Jocasta Neuroscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SC8 Investments | Series A |
| Moore Strategic Ventures | Series A |
| Glentura | Series A |
| Moore Capital Management | Series A |
| True Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 12, 2025
$35M round led by True Ventures
For institutional investors. Book with your work email.
Jocasta Neuroscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Jocasta Neuroscience's valuation, stock price, and market status.
Is Jocasta Neuroscience a public or private company?
Jocasta Neuroscience is a private company.
What is the current stock price of Jocasta Neuroscience?
Jocasta Neuroscience is a private company, so its shares have no public market price. Caplight tracks Jocasta Neuroscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Jocasta Neuroscience worth (valuation)?
Valuation information for Jocasta Neuroscience is not publicly available.
Can I buy Jocasta Neuroscience stock?
Jocasta Neuroscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Jocasta Neuroscience's last funding round?
Jocasta Neuroscience's most recent funding round was Series A on August 12, 2025.
Who are the main investors in Jocasta Neuroscience?
Key investors in Jocasta Neuroscience include True Ventures.
Will Jocasta Neuroscience IPO soon?
No public IPO plans have been announced for Jocasta Neuroscience.
How can I track Jocasta Neuroscience secondary market activity?
Caplight tracks bids, offers, and trades in Jocasta Neuroscience's shares on secondary markets.